Blueprint Medicines Corporation revenue breakdown overview

Blueprint Medicines Corporation revenue for the last year amounted to 249.38 M USD, the most of which — 249.38 M USD — came from its highest performing source at the moment, Precision Therapies, the year earlier bringing 204.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Blueprint Medicines Corporation 227.14 M USD, and the year before that — 190.27 M USD.